tradingkey.logo

Zymeworks Outlines Strategic Priorities And Outlook For 2026

ReutersJan 11, 2026 11:03 PM

- Zymeworks Inc ZYME.O:

  • ZYMEWORKS OUTLINES STRATEGIC PRIORITIES AND OUTLOOK FOR 2026

  • ZYMEWORKS: UP TO $440 MILLION IN MILESTONE PAYMENTS ELIGIBLE TO BE EARNED RELATED TO REGULATORY APPROVALS OF ZIIHERA IN GEA IN UNITED STATES, EUROPE, JAPAN, & CHINA

  • ZYMEWORKS INC: GLOBAL PHASE 1 CLINICAL TRIAL INVESTIGATING ZW191 IN SOLID TUMORS IS ONGOING WITH DOSE OPTIMIZATION OF ZW191 IN OVARIAN CANCER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI